Connecticut Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,484
Closed -$318K 192
2022
Q1
$318K Sell
2,484
-12
-0.5% -$1.31K 0.02% 148
2021
Q4
$335K Hold
2,496
0.03% 152
2021
Q3
$341K Buy
2,496
+80
+3% +$10.1K 0.03% 145
2021
Q2
$258K Buy
+2,416
New +$232K 0.02% 166

Other funds holding DXCM

Connecticut Wealth Management's DXCM Position: Q2 2022 in Review

Connecticut Wealth Management sold out of DexCom (DXCM) in Q2 2022, closing a stake of 2,484 shares — an estimated $318K sold.

Connecticut Wealth Management first reported a position in DXCM in Q2 2021 and held it in 4 quarters. The position peaked at $341K in Q3 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Connecticut Wealth Management reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Connecticut Wealth Management sold 2,484 DexCom shares in Q2 2022, an estimated $318K.
  • Connecticut Wealth Management first reported a position in DexCom in Q2 2021 and held it in 4 quarters.
  • Connecticut Wealth Management's DexCom position peaked at $341K in Q3 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Connecticut Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.